Andrew, this is a growth stock...
EBITDA to 31/12/07 was $18M
EBITDA for half year to 30/6/08 will be $27M, which is 50% growth over one half...
EBITDA to 31/12/08 may be $33M, which will be 83% growth over the previous period...
EBITDA for full year to 31/12/08 may be $70+M, which will be 56% growth over the previous year...
- Forums
- ASX - By Stock
- COF
- oversold
oversold, page-10
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add COF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.22 |
Change
0.000(0.00%) |
Mkt cap ! $725.7M |
Open | High | Low | Value | Volume |
$1.23 | $1.24 | $1.22 | $470.5K | 384.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 14712 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 13386 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 14712 | 1.220 |
13 | 28638 | 1.215 |
12 | 33045 | 1.210 |
9 | 19486 | 1.205 |
6 | 40219 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.225 | 13386 | 15 |
1.230 | 76213 | 15 |
1.235 | 45556 | 10 |
1.240 | 12488 | 8 |
1.245 | 7145 | 2 |
Last trade - 14.17pm 15/07/2024 (20 minute delay) ? |
Featured News
COF (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online